Daichuan Medical

Shanghai Daichuan Medical Technology Co., Ltd. (Daichuan Medical) is a specialized healthcare technology company focused on the development of non-invasive brain stimulation (NIBS) and neuro-rehabilitation devices. Based in Shanghai, the company leverages advancements in neuroscience and digital health to provide solutions for neurological and psychiatric disorders, including stroke, depression, and Parkinson's disease. Their core product offerings include transcranial direct current stimulation (tDCS) and transcranial magnetic stimulation (TMS) systems designed for both clinical and home-based use. Daichuan Medical integrates brain-computer interface (BCI) technology and digital therapeutics into its platform to provide personalized, data-driven rehabilitation solutions. The company is backed by prominent investors such as Sequoia China and ZhenFund, reflecting its position as an innovator in the Chinese neuromodulation market.